Ambreen Sonawalla, Daniel I Chasman, Yee-Ming Chan
{"title":"Age at Menarche and Coronary Artery Disease Risk: Divergent Associations with Different Sources of Variation.","authors":"Ambreen Sonawalla, Daniel I Chasman, Yee-Ming Chan","doi":"10.1210/clinem/dgaf141","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In women, both earlier and later age at menarche (AAM) are associated with increased risk of coronary artery disease (CAD). This study examined if the relationship of AAM with CAD and CAD risk factors differs for different underlying sources of variation in AAM - specifically, variation attributable to common genetic variants, as represented by a polygenic score (PGS), vs. variation in AAM independent of the PGS (e.g., from environment, rare genetic variants).</p><p><strong>Methods: </strong>Primary analyses were conducted on data from 201,037 women in the UK Biobank and validation studies on data from 23,268 women in the Women's Genome Health Study (WGHS). For each individual, a PGS for AAM was calculated, then two variables were estimated from linear regression models: genetically predicted AAM (the estimated AAM for each woman solely due to the effects of common genetic variants) and PGS-adjusted AAM (the estimated AAM for each woman solely due to factors other than the PGS). Logistic regression and linear splines were then used to study the relationships of these variables with CAD and CAD risk factors.</p><p><strong>Results: </strong>Genetically predicted AAM demonstrated linear or roughly linear relationships with CAD and CAD risk factors. In contrast, PGS-adjusted AAM demonstrated a U-shaped relationship with CAD, hemoglobin A1c, triglycerides, HDL-C, and waist-hip ratio.</p><p><strong>Conclusions: </strong>These results are consistent with earlier AAM causally increasing risk of CAD but suggest that later AAM itself does not cause increased risk of CAD; rather, sources of variation in AAM other than common genetic variants can cause both later AAM and increased risk of CAD. Dysglycemia, dyslipidemia, and central adiposity are candidate mediators of the association of later AAM with increased risk of CAD.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgaf141","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In women, both earlier and later age at menarche (AAM) are associated with increased risk of coronary artery disease (CAD). This study examined if the relationship of AAM with CAD and CAD risk factors differs for different underlying sources of variation in AAM - specifically, variation attributable to common genetic variants, as represented by a polygenic score (PGS), vs. variation in AAM independent of the PGS (e.g., from environment, rare genetic variants).
Methods: Primary analyses were conducted on data from 201,037 women in the UK Biobank and validation studies on data from 23,268 women in the Women's Genome Health Study (WGHS). For each individual, a PGS for AAM was calculated, then two variables were estimated from linear regression models: genetically predicted AAM (the estimated AAM for each woman solely due to the effects of common genetic variants) and PGS-adjusted AAM (the estimated AAM for each woman solely due to factors other than the PGS). Logistic regression and linear splines were then used to study the relationships of these variables with CAD and CAD risk factors.
Results: Genetically predicted AAM demonstrated linear or roughly linear relationships with CAD and CAD risk factors. In contrast, PGS-adjusted AAM demonstrated a U-shaped relationship with CAD, hemoglobin A1c, triglycerides, HDL-C, and waist-hip ratio.
Conclusions: These results are consistent with earlier AAM causally increasing risk of CAD but suggest that later AAM itself does not cause increased risk of CAD; rather, sources of variation in AAM other than common genetic variants can cause both later AAM and increased risk of CAD. Dysglycemia, dyslipidemia, and central adiposity are candidate mediators of the association of later AAM with increased risk of CAD.
期刊介绍:
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.